Annotation Detail

Information
Associated Genes
CEBPA
Associated Variants
CEBPA MUTATION
CEBPA MUTATION
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
Overall survival and remission duration were significantly longer (p=0.01 and p=0.05, respectively) in younger (16-60), cytogenetically normal acute myeloid leukemia patients with CEBPA mutations (21/236 patients).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/168
Gene URL
https://civic.genome.wustl.edu/links/genes/15
Variant URL
https://civic.genome.wustl.edu/links/variants/29
Rating
3
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Better Outcome
Pubmed
14726504
Drugs